Meeting Scheduled on Changes in Supplement Industry as Part of FDA's Modernization of Regulatory Oversight
April 11, 2019 at 05:43 AM EST
The FDA wants stakeholder input on new developments in the dietary supplement marketplace, and is scheduling a public meeting and opening a comment docket to receive the feedback.
The purpose behind the May 16 meeting is to gather comments on “facilitating responsible innovation in the dietary supplement industry” that will not compromise the FDA’s ability to protect the publ... Read More
